NEOPHOTONICS CORP Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization
Stock-based compensation expense
Deferred taxes
Amortization of investment, debt and other
Gain on disposal of property and equipment
Amortization of operating lease right-of-use assets
Net loss recovery from litigation settlement
Gain on foreign currency hedges
Allowance for doubtful accounts
Write-down of inventories
Foreign currency remeasurement and other, net
Issuance of common stock in exchange for research and development services
Asset impairment charges
Adjustment to fair value of Rusnano payment derivative
Change in assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other assets
Accounts payable
Accrued and other liabilities

Net cash provided by (used in) operating activities
Cash flows from investing activities
Purchase of property, plant and equipment
Proceeds from sale of property, plant and equipment and other assets
Purchase of marketable securities
Proceeds from sale of marketable securities
Proceeds from maturity of marketable securities
Change in restricted cash
Restricted cash payable related to asset sale
Settlement of foreign currency hedges
Acquisition of businesses, net
Net cash used in investing activities

Cash flows from financing activities
Proceeds from exercise of stock options and issuance of stock under ESPP
Offering costs
Tax withholding on restricted stock units
Payments for public stock offering, net of offering costs
Proceeds from bank loans
Repayment of bank loans
Proceeds from issuance of notes payable
Repayment of finance lease liabilities
Repayment of notes payable
Proceeds from (repayment of) government grants
Net cash provided by (used in) financing activities
Effect of exchange rates on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the period
Cash and cash equivalents at the end of the period
Effect of exchange rates on cash, cash equivalents and restricted cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of the period
Cash, cash equivalents and restricted cash at the end of the period
Supplemental disclosure of cash flow information:
Cash paid for income taxes
Cash paid for interest
Net cash paid for income taxes

Supplemental disclosure of noncash investing and financing activities:
Restricted cash receipt and payable related to asset purchase agreement
Unpaid deferred offering costs
Neo Russia penalty settlement
Debt interest rolled into principal
Government approved expenditures incurred after receipt of government funds
Decrease (increase) in unpaid property, plant and equipment
Modification of bank loan with Comerica
Issuance of note to seller of acquired business
Transfer of restricted investments to short-term investments
Capital lease
Asset retirement obligation
Unpaid property, plant and equipment
Right-of-use assets obtained in exchange for lease obligations

Comments